Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Apetoh, Lionel, Ghiringhelli, François, Tesniere, Antoine, Obeid, Michel, Ortiz, Carla, Criollo, Alfredo, Mignot, Grégoire, Maiuri, M Chiara +20 more·2007·Nature Medicine
DOI 10.1038/nm1622

Cited by (1,009)

Items 601–700 of 1,009

  1. Damage-associated molecular patterns in tumor radiotherapy
    Milad Ashrafizadeh, Bagher Farhood, Ahmed Eleojo Musa, Shahram Taeb, Masoud Najafi · 2020 · International Immunopharmacology
  2. Dual Therapeutic Efficacy of Vinblastine as a Unique Chemotherapeutic Agent Capable of Inducing Dendritic Cell Maturation
    Tanaka, Hiroaki, Matsushima, Hironori, Nishibu, Akiko, Clausen, Björn E., Takashima, Akira · 2009 · Cancer Research
  3. The prognostic and predictive value of tumor-infiltrating lymphocytes and hematologic parameters in patients with breast cancer
    Kwan Ho Lee, Eun Young Kim, Ji‐Sup Yun, Yong Lai Park, Sung‐Im Do, Seoung Wan Chae, Chan Heun Park · 2018 · BMC Cancer
  4. Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: an update review
    Zhai, Jiaqi, Gu, Xi, Liu, Yang, Hu, Yueting, Jiang, Yi, Zhang, Zhenyong · 2023 · Frontiers in Pharmacology
  5. Chemotherapy remains an essential element of personalized care for persons with lung cancers
    Matthew David Hellmann, Bingyu Li, Jamie E. Chaft, Mark G. Kris · 2016 · Annals of Oncology
  6. Mechanisms of Regulated Cell Death: Current Perspectives
    Sara Francesca Santagostino, Charles‐Antoine Assenmacher, James C. Tarrant, Adeyemi O. Adedeji, Enrico Radaelli · 2021 · Veterinary Pathology
  7. Interferons and the immunogenic effects of cancer therapy
    Minn, Andy J. · 2015 · Trends in Immunology
  8. Links between Innate Immunity and Normal Tissue Radiobiology
    Dörthe Schaue, William H. McBride · 2010 · Radiation Research
  9. Review of the Molecular Pathogenesis of Osteosarcoma
    Jinpeng He, Yun Xiu Hao, Xiaolin Wang, Xiao-jin Yang, Jingfan Shao, Feng-Jin Guo, Jiexiong Feng · 2014 · Asian Pacific Journal of Cancer Prevention
  10. Chemotherapy and immunotherapy: mapping the road ahead
    Alistair Cook, Willem Joost Lesterhuis, Anna K. Nowak, Richard Lake · 2015 · Current Opinion in Immunology
  11. Biomarkers of Radiotherapy-Induced Immunogenic Cell Death
    Rianne D.W. Vaes, Lizza E.L. Hendriks, Marc Vooijs, Dirk De Ruysscher · 2021 · Cells
  12. The Human <i>TLR</i> Innate Immune Gene Family Is Differentially Influenced by DNA Stress and <i>p53</i> Status in Cancer Cells
    Shatz, Maria, Menendez, Daniel, Resnick, Michael A. · 2012 · Cancer Research
  13. Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
    Mathieu Wémeau, Oliver Kepp, Antoine Tesnière, Theocharis Panaretakis, Caroline Flament, Stéphane de Botton, Laurence Zitvogel, Guido Kroemer, Nathalie Chaput · 2010 · Cell Death and Disease
  14. Combinatorial prospects of nano-targeted chemoimmunotherapy
    Candido G. Da Silva, Félix Rueda, Clemens W.G.M. Löwik, FERRY A. OSSENDORP, Luis Javier Cruz · 2016 · Biomaterials
  15. Macrophage biology plays a central role during ionizing radiation-elicited tumor response
    Qiuji Wu, Awatef Allouch, Isabelle Martins, Nazanine Modjtahedi, Éric Deutsch, Jean‐Luc Perfettini · 2017 · Biomedical Journal
  16. Immunogenic Apoptosis as a Novel Tool for Anticancer Vaccine Development
    Barbara Montico, Annunziata Nigro, Vincenzo Casolaro, Jessica Dal Col · 2018 · International Journal of Molecular Sciences
  17. Type I IFN protects cancer cells from CD8+ T cell–mediated cytotoxicity after radiation
    Jianzhou Chen, Yunhong Cao, Boštjan Markelc, Jakob Kaeppler, Jenny A. F. Vermeer, Ruth J. Muschel · 2019 · Journal of Clinical Investigation
  18. Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy.
    2017 · Cancer Research
  19. A nnexin A 2 complexes with S 100 proteins: structure, function and pharmacological manipulation
    Yidong Liu, Helene K. Myrvang, Lodewijk V. Dekker · 2014 · British Journal of Pharmacology
  20. The Tumor-Immune Microenvironment and Response to Radiation Therapy
    Stephen Lawrence Shiao, Lisa M. Coussens · 2010 · Journal of Mammary Gland Biology and Neoplasia
  21. Prospects for TIM3-Targeted Antitumor Immunotherapy.
    S. Ngiow, M. Teng, M. Smyth · 2011 · Cancer Research
  22. Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance
    Alessandra Zingoni, Cinzia Fionda, Cristiana Borrelli, Marco Cippitelli, Angela Santoni, Alessandra Soriani · 2017 · Frontiers in Immunology
  23. Treatment of Canine Oral Melanoma with Nanotechnology-Based Immunotherapy and Radiation
    Paul Jack Hoopes, Robert J. Wagner, Kayla E. A. Duval, Kevin Kang, David J. Gladstone, Karen L Moodie, Margaret Crary-Burney, Hugo Arias‐Pulido, Frank A. Veliz, Nicole F. Steinmetz et al. · 2018 · Molecular Pharmaceutics
  24. Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first‐line treatment of advanced esophageal squamous cell carcinoma
    Bo Zhang, Ling Yan Qi, Xi Wang, Jianping Xu, Yun Liu, Lan Mu, Xingyuan Wang, Lidan Bai, Jing Huang · 2020 · 癌症：英文版
  25. TLR-2 and TLR-9 are sensors of apoptosis in a mouse model of doxorubicin-induced acute inflammation
    Dmitri V. Krysko, Agnieszka Kaczmarek, Olga Krysko, Leo Heyndrickx, J. Woznicki, Pieter Bogaert, Anje Cauwels, Nozomi Takahashi, Stefan Magez, Claus Bachert et al. · 2011 · Cell Death and Differentiation
  26. IFN-γ Mediates the Antitumor Effects of Radiation Therapy in a Murine Colon Tumor
    Scott A. Gerber, Abigail L. Sedlacek, Kyle R. Cron, Shawn P. Murphy, John G. Frelinger, Edith M. Lord · 2013 · American Journal Of Pathology
  27. Radiotherapy-Induced Anti-Tumor Immunity Contributes to the Therapeutic Efficacy of Irradiation and Can Be Augmented by CTLA-4 Blockade in a Mouse Model
    Yuya Yoshimoto, Yoshiyuki Suzuki, Kousaku Mimura, Ken Ando, Takahiro Oike, Hiro Sato, Noriyuki Okonogi, Takanori Maruyama, Shinichirou Izawa, Shin‐ei Noda et al. · 2014 · PLoS ONE
  28. Adaptive immunity after cell death
    Santiago Zelenay, Caetano Reis e Sousa · 2013 · Trends in Immunology
  29. Development of nanotechnology-mediated precision radiotherapy for anti-metastasis and radioprotection
    Yuan‐Bo Pan, Wei Tang, Wenpei Fan, Jianmin Zhang, Xiaoyuan Shawn Chen · 2022 · Chemical Society Reviews
  30. Immunosurveillance in clinical cancer management
    Guido Kroemer, Timothy An-thy Chan, Alexander M.M. Eggermont, Lorenzo Galluzzi · 2023 · CA A Cancer Journal for Clinicians
  31. HPMA Copolymer Conjugates of Paclitaxel and Docetaxel with pH-Controlled Drug Release
    Tomáš Etrych, Milada Šírová, Larisa Starovoytová, Blanka Řı́hová, Karel Ulbrich · 2010 · Molecular Pharmaceutics
  32. Cetuximab-mediated Tumor Regression Depends on Innate and Adaptive Immune Responses
    Xuanming Yang, Xunmin Zhang, Eric D. Mortenson, Olga Radkevich-Brown, Yang Wang, Yang‐Xin Fu · 2012 · Molecular Therapy
  33. DAMPs in the immunogenicity of cell death
    Ruochan Chen, Ju Zou, Jiao Liu, Rui Kang, Daolin Tang · 2025 · Molecular Cell
  34. Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase–positive anaplastic large cell lymphoma with tumor dissemination and relapse risk
    Kamel Ait‐Tahar, Christine Damm‐Welk, Birgit Burkhardt, Martin Zimmermann, Wolfram Klapper, Alfred Reiter, Karen A. F. Pulford, Wilhelm Woessmann · 2010 · Blood
  35. Toll-like Receptor 4 (TLR4) Is Essential for Hsp70-like Protein 1 (HSP70L1) to Activate Dendritic Cells and Induce Th1 Response
    Hongliang Fang, Yanfeng Wu, Xiaohui Huang, Wenying Wang, Bing Ang, Xuetao Cao, Tao Yu Wan · 2011 · Journal of Biological Chemistry
  36. Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
    Hye Won Chung, Sang‐Guk Lee, Heejung Kim, Duck Jin Hong, Jae Bock Chung, David Stroncek, Jong‐Baeck Lim · 2009 · Journal of Translational Medicine
  37. Why Target Immune Cells for Plasma Treatment of Cancer
    Vandana Miller, Abraham G. Lin, Alexander Fridman · 2015 · Plasma Chemistry and Plasma Processing
  38. Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death
    Kun Tu, Huan Deng, Li Kong, Yi Wang, Ting Yang, Qian Hu, Mei Ying Hu, Conglian Yang, Zhiping Zhang · 2020 · ACS Applied Materials & Interfaces
  39. Immunogenic cell death in colon cancer prevention and therapy
    Hang Ruan, Brian J. Leibowitz, Lin Zhang, Jian Yu · 2020 · Molecular Carcinogenesis
  40. From Immunogenic Cell Death to Immunogenic Modulation: Select Chemotherapy Regimens Induce a Spectrum of Immune-Enhancing Activities in the Tumor Microenvironment
    Kellsye P. Fabian, Benjamin Wolfson, James W. Hodge · 2021 · Frontiers in Oncology
  41. Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer
    Joji Kitayama, Koji Yasuda, Kazushige Kawai, Eiji Sunami, Hirokazu Nagawa · 2011 · BMC Cancer
  42. Genotoxic stress modulates the release of exosomes from multiple myeloma cells capable of activating NK cell cytokine production: Role of HSP70/TLR2/NF-kB axis
    Elisabetta Vulpis, Francesca Cecere, Rosa Molfetta, Alessandra Soriani, Cinzia Fionda, Giovanna Peruzzi, Giulio Caracciolo, Sara Palchetti, Laura Masuelli, Lucilla Simonelli et al. · 2017 · OncoImmunology
  43. The dual role and therapeutic potential of high-mobility group box 1 in cancer
    Si-Jia He, Jin Quan Cheng, Feng Xiao, Yang Yu, Ling Tian, Qian Huang · 2017 · Oncotarget
  44. Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression.
    Graeme J. Koelwyn, Erik Wennerberg, Sandra Demaria, Lee W. Jones · 2015 · PubMed
  45. Significance of tumor‐infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer
    Shinji Matsutani, Masatsune Shibutani, Kiyoshi Maeda, Hisashi Nagahara, Tatsunari Fukuoka, Shigetomi Nakao, Kosei Hirakawa, Masaichi Ohira · 2018 · Cancer Science
  46. A biomaterial-based vaccine eliciting durable tumour-specific responses against acute myeloid leukaemia
    Nisarg J. Shah, Alexander J. Najibi, Ting‐Yu Shih, Angelo S. Mao, Azeem Sharda, David T. Scadden, David J. Mooney · 2020 · Nature Biomedical Engineering
  47. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin
    Roberta Tufi, Theocharis Panaretakis, Katiuscia Bianchi, Alfredo Criollo, Barbara Fazi, Federica Di Sano, Antoine Tesnière, Oliver Kepp, Patrizia Paterlini-Bréchot, Laurence Zitvogel et al. · 2007 · Cell Death and Differentiation
  48. Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo
    Tongu, Miki, Harashima, Nanae, Monma, Hiroyuki, Inao, Touko, Yamada, Takaya, Kawauchi, Hideyuki, Harada, Mamoru · 2013 · Cancer Immunology, Immunotherapy
  49. Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.
    Feifei Teng, Dianbin Mu, Xiangjiao Meng, Li Kong, Hui Zhu, Sujing Liu, Jianbo Zhang, Jinming Yu · 2015 · Europe PMC (PubMed Central)
  50. Dendritic cell vaccines in melanoma: From promise to proof?
    Willem Joost Lesterhuis, Erik H.J.G. Aarntzen, I. Jolanda M. de Vries, Danita H. Schuurhuis, Carl Gustav Figdor, Gosse J. Adema, Cornelis J.A. Punt · 2008 · Critical Reviews in Oncology/Hematology
  51. Mechanisms linking pathogens-associated inflammation and cancer
    Porta, Chiara, Riboldi, Elena, Sica, Antonio · 2011 · Cancer Letters
  52. The synergistic effect of radiotherapy and immunotherapy: A promising but not simple partnership
    É. Chajon, Joël Castelli, Hugo Raul Marsiglia, R. de Crevoisier · 2017 · Critical Reviews in Oncology/Hematology
  53. Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors
    Madhav D. Sharma, Paulo C. Rodrı́guez, Brent H. Koehn, Babak Baban, Yan Ru Cui, Gang Guo, Michiko Shimoda, Rafał Pacholczyk, Huidong Shi, Eun-Joon Lee et al. · 2018 · Immunity
  54. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice
    Guohao Wang, Junji Xu, Jiang‐Sha Zhao, Weiqin Yin, Dayong Liu, Wanjun Chen, Xianyu Steven Hou · 2020 · Nature Communications
  55. Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
    Inge Compter, Daniëlle B. P. Eekers, Ann Hoeben, Kasper M. A. Rouschop, Bart J.T. Reymen, Linda P.C.M. Ackermans, Jan Beckervordersantforth, Noël J.C. Bauer, Monique H. M. E. Anten, Pieter Wesseling et al. · 2020 · Autophagy
  56. Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations
    Kyu-Won Lee, Judy Wai Ping Yam, Xiaowen Mao · 2023 · Cells
  57. Bleomycin Exerts Ambivalent Antitumor Immune Effect by Triggering Both Immunogenic Cell Death and Proliferation of Regulatory T Cells
    Hélène Bugaut, Mélanie Bruchard, Hélène Berger, Valentin Dérangère, Ludivine Odoul, Romain Euvrard, Sylvain Ladoire, Fanny Chalmin, Frédérique Végran, Cédric Rébé et al. · 2013 · PLoS ONE
  58. Immunogenicity of anthracyclines: moving towards more personalized medicine
    Lionel Apétoh, Grégoire Mignot, Theocharis Panaretakis, Guido Kroemer, Laurence Zitvogel · 2008 · Trends in Molecular Medicine
  59. Negative regulation of type I IFN signaling
    Arimoto, Kei-Ichiro, Miyauchi, Sayuri, Stoner, Samuel A, Fan, Jun-Bao, Zhang, Dong-Er · 2018 · Journal of Leukocyte Biology
  60. The interplay between HPV and host immunity in head and neck squamous cell carcinoma
    Anne S. M. Andersen, Anne Sophie Sølling, Therese Ovesen, Maria Rusan · 2013 · International Journal of Cancer
  61. Toll-like receptors: lessons to learn from normal and malignant human B cells
    David Chiron, Isabelle Bekeredjian‐Ding, Catherine Pellat‐Deceunynck, Régis Bataille, Gaëtan Jégo · 2008 · Blood
  62. Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells
    Jinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa, Jorrit De Waele, Jonas R.M. Van Audenaerde, Elly Marcq, Julie Jacobs, Abraham G. Lin, Eva Lion, Heleen Dewitte et al. · 2019 · Cancers
  63. Inhibition of Immunosuppressive Tumors by Polymer‐Assisted Inductions of Immunogenic Cell Death and Multivalent PD‐L1 Crosslinking
    Lian Li, Yachao Li, Chieh‐Hsiang Yang, D. Christopher Radford, Jiawei Wang, Margit-M Janat-Amsbury, Jindŕich Kopec̆ek, Jiyuan Yang · 2020 · Advanced Functional Materials
  64. Targeting Innate Immunity in Cancer Therapy
    Srikrishnan Rameshbabu, Brian William Labadie, Anna Argulian, Akash Patnaik · 2021 · Vaccines
  65. Belantamab Mafodotin (GSK2857916) Drives Immunogenic Cell Death and Immune-mediated Antitumor Responses In Vivo
    Rocio Montes De Oca, Alireza Alavi, Nick Vitali, Sabyasachi Bhattacharya, Christina Blackwell, Krupa J. Patel, Laura Seestaller‐Wehr, Heather Kaczynski, Hong Shi, Eric Dobrzynski et al. · 2021 · Molecular Cancer Therapeutics
  66. Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness
    Robby Barnestein, Loïck Galland, Laura Kalfeist, François Ghiringhelli, Sylvain Ladoire, Emeric Limagne · 2022 · OncoImmunology
  67. The immunogenicity of tumor cell death
    Oliver Kepp, Antoine Tesnière, Laurence Zitvogel, Guido Kroemer · 2008 · Current Opinion in Oncology
  68. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer
    Ladoire, Sylvain, Enot, David, Senovilla, Laura, Ghiringhelli, François, Poirier-Colame, Vichnou, Chaba, Kariman, Semeraro, Michaela, Chaix, Marie, Penault-Llorca, Frédérique, Arnould, Laurent et al. · 2016 · Autophagy
  69. Role of tumour-associated macrophages in cancer-related inflammation.
    Antonio Sica · 2010 · PubMed
  70. Highly Integrated Nano-Platform for Breaking the Barrier between Chemotherapy and Immunotherapy
    Diwei Zheng, Jiali Chen, Jingyi Zhu, Lei Rong, Bin Li, Qi Lei, Jin‐Xuan Fan, Mei‐Zhen Zou, Cao Li, Si‐Xue Cheng et al. · 2016 · Nano Letters
  71. The power of small changes: Comprehensive analyses of microbial dysbiosis in breast cancer
    Sheetal Parida, Dipali Sharma · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  72. DNA damage enhancement by radiotherapy-activated hafnium oxide nanoparticles improves cGAS-STING pathway activation in human colorectal cancer cells
    Julie Marill, Naeemunnisa Mohamed Anesary, Sébastien Paris · 2019 · Radiotherapy and Oncology
  73. Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells–Peritoneal Stroma Interactions
    Michela Terri, Flavia Trionfetti, Claudia Montaldo, Marco Cordani, Marco Tripodi, Manuel López‐Cabrera, Raffaele Strippoli · 2021 · Frontiers in Immunology
  74. Prognostic and therapeutic role of tumor-infiltrating lymphocyte subtypes in breast cancer
    Molly A. Nelson, Worapol Ngamcherdtrakul, Shiuh-Wen Luoh, W. Yantasee · 2021 · Cancer Metastasis Review
  75. Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies
    Steve Pascolo · 2015 · European Journal of Pharmacology
  76. Can immunostimulatory agents enhance the abscopal effect of radiotherapy?
    Antonin Lévy, Cyrus Chargari, Aurélien Marabelle, Jean‐Luc Perfettini, Nicolas Magné, Éric Deutsch · 2016 · European Journal of Cancer
  77. Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
    Eduardo Huarte, Juan R. Cubillos‐Ruiz, Yolanda C. Nesbeth, Uciane K. Scarlett, Diana G. Martinez, Ronald J. Buckanovich, Fabián Benencia, Radu V. Stan, Tibor Keler, Pablo Sarobe et al. · 2008 · Cancer Research
  78. eIF2α phosphorylation as a biomarker of immunogenic cell death
    Oliver Kepp, Michaëla Semeraro, José Manuel Bravo‐San Pedro, Norma Bloy, Aitziber Buqué, Xing Huang, Heng Zhou, Laura Senovilla, Guido Kroemer, Lorenzo Galluzzi · 2015 · Seminars in Cancer Biology
  79. Immunogenic Cell Death: Can It Be Exploited in PhotoDynamic Therapy for Cancer?
    Elisa Panzarini, Valentina Inguscio, Luciana Dini · 2012 · BioMed Research International
  80. Polyhydroxylated Metallofullerenols Stimulate IL‐1β Secretion of Macrophage through TLRs/MyD88/NF‐κB Pathway and NLRP3 Inflammasome Activation
    Zhiyun Chen, Ying Liu, Baoyun Sun, Han Li, Jinquan Dong, Lijuan Zhang, Liming Wang, Peng Wang, Yuliang Zhao, Chunying Chen · 2014 · Small
  81. Nano-Pulse Stimulation is a physical modality that can trigger immunogenic tumor cell death
    Richard Nuccitelli, Amanda E. McDaniel, Snjezana Anand, John Cha, Zachary O. Mallon, Jon Casey Berridge, Darrin R. Uecker · 2017 · Journal for ImmunoTherapy of Cancer
  82. The role of toll-like receptor 4 in tumor microenvironment
    Jing Li, Fan Yang, Feng Wei, Xiubao Ren · 2017 · Oncotarget
  83. Turning tumors from cold to inflamed to improve immunotherapy response
    Camille Lea Gerard, Julie Delyon, Alexandre M. Wicky, Krisztián Homicskó, Michel A. Cuendet, Olivier Alain Michielin · 2021 · Cancer Treatment Reviews
  84. Trial watch
    Erika Vacchelli, Lorenzo Galluzzi, Wolf H. Fridman, Jérôme Galon, Catherine Sautès‐Fridman, Éric Tartour, Guido Kroemer · 2012 · OncoImmunology
  85. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells
    Kamolporn Amornsupak, Tonkla Insawang, Peti Thuwajit, Pornchai O‐charoenrat, Suzanne A. Eccles, Chanitra Thuwajit · 2014 · BMC Cancer
  86. Immune Adjuvant Efficacy of CpG Oligonucleotide in Cancer Treatment Is Founded Specifically upon TLR9 Function in Plasmacytoid Dendritic Cells
    Stefan Nierkens, Martijn H. den Brok, Zacharias Garcia, Susan Togher, Jori A. L. Wagenaars, Melissa Wassink, Louis Boon, Theo J. M. Ruers, Carl Gustav Figdor, Stephen Philip Schoenberger et al. · 2011 · Cancer Research
  87. Sepsis and Cancer: An Interplay of Friends and Foes
    Adrien Mirouse, Clara Vigneron, Jean‐François Llitjos, Jean‐Daniel Chiche, Jean Paul Mira, Djamel Mokart, Élie Azoulay, Frédéric Pène · 2020 · American Journal of Respiratory and Critical Care Medicine
  88. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer
    Sylvain Ladoire, Frederique Madeleine Penault-Llorca, Laura Senovilla, Cécile Dalban, David Pierre Enot, Clara Locher, Nicole Prada, Vichnou Poirier-Colame, Kariman Chaba, Laurent Arnould et al. · 2015 · Autophagy
  89. Immunologically augmented cancer treatment using modern radiotherapy
    Marco Durante, Norman Reppingen, Kathryn D. Held · 2013 · Trends in Molecular Medicine
  90. Tumour Immunogenicity, Antigen Presentation, and Immunological Barriers in Cancer Immunotherapy
    David Escors · 2014 · New Journal of Science
  91. Production of Adenosine by Ectonucleotidases: A Key Factor in Tumor Immunoescape
    François Ghiringhelli, Mélanie Bruchard, Fanny Chalmin, Cédric Rébé · 2012 · BioMed Research International
  92. Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer
    Patrick G. Gavin, Nan Song, S. Rim Kim, Corey Lipchik, Nicole L. Johnson, Hanna Bandos, Melanie Finnigan, Priya Rastogi, Louis Fehrenbacher, Eleftherios P. Mamounas et al. · 2016 · JAMA Oncology
  93. Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
    Gi‐Hoon Nam, Eun Jung Lee, Yoon Kyoung Kim, Yeonsun Hong, Yoonjeong Choi, Myung‐Jeom Ryu, Jiwan Woo, Yakdol Cho, Dong June Ahn, Yoosoo Yang et al. · 2018 · Nature Communications
  94. Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside.
    M. Jinushi, Yoshihiro Komohara · 2015 · Biochimica et Biophysica Acta
  95. An Elevated Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Favorable Response and Prognosis in Locally Advanced Breast Cancer following Neoadjuvant Chemotherapy
    Xiaojian Ni, Xiao-Lan Zhang, Qianwen Ouyang, Guo-Wei Qian, Lei Wang, Sheng Chen, Yi-Zhou Jiang, Wen‐Jia Zuo, Jiong Wu, Xin Hu et al. · 2014 · PLoS ONE
  96. Solid Tumors Challenges and New Insights of CAR T Cell Engineering
    Safa Tahmasebi, Reza Elahi, Abdolreza Esmaeilzadeh · 2019 · Stem Cell Reviews and Reports
  97. Tumor Microenvironment as a Regulator of Radiation Therapy: New Insights into Stromal-Mediated Radioresistance
    Varintra E. Krisnawan, Jennifer Anne Stanley, Julie Kristina Schwarz, David G. DeNardo · 2020 · Cancers
  98. Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
    Awalpreet Singh Chadha, Guan Liu, Hsiang-Chun Chen, Prajnan Das, Bruce D. Minsky, Usama X. Mahmood, Marc E. Delclos, Yelin Suh, Gabriel Oliveira Sawakuchi, Sam A. Beddar et al. · 2016 · International Journal of Radiation Oncology*Biology*Physics
  99. Targeting Toll-Like Receptors for Cancer Therapy
    Marc J. Braunstein, John Ross Kucharczyk, Sylvia Adams · 2018 · Targeted Oncology
  100. Understanding and Managing Sepsis in Patients With Cancer in the Era of Antimicrobial Resistance
    Carlota Gudiol, Adaia Albasanz‐Puig, Guillermo Cuervo, Jordi Carratalà · 2021 · Frontiers in Medicine